Belgium
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 37.77 B |
Jan. 14, 2025 | USD 195.15 | -0.39% |
|
Belgium |
|
2 |
USD 6.87 B |
Jan. 14, 2025 | USD 150.68 | -0.48% |
|
Belgium |
|
3 |
USD 4.69 B |
Jan. 14, 2025 | USD 19.13 | -0.63% |
|
Belgium |
|
4 |
USD 1.68 B |
Jan. 14, 2025 | USD 24.20 | -0.41% |
|
Belgium |
|
5 |
USD 1.22 B |
Jan. 14, 2025 | USD 19.81 | 0.71% |
|
Belgium |
|
6 |
USD 402.37 M |
Jan. 14, 2025 | USD 13.71 | -0.44% |
|
Belgium |
|
7 |
USD 124.57 M |
Jan. 14, 2025 | USD 3.28 | -5.91% |
|
Belgium |
The Biotechnology company in Belgium with the highest Market Capitalization is UCB SA (Brussels Stock Exchange: UCB.BR) at USD 37.77 B.
The Biotechnology company in Belgium with the lowest Market Capitalization is Biotalys NV (Brussels Stock Exchange: BTLS.BR) at USD 124.57 M.
The top 10 Biotechnology companies in Belgium by Market Capitalization are UCB SA, Financière de Tubize SA, Azelis Group NV, Galapagos NV, Tessenderlo Group NV, Ion Beam Applications SA and Biotalys NV.
The bottom 10 Biotechnology companies in Belgium by Market Capitalization are Biotalys NV, Ion Beam Applications SA, Tessenderlo Group NV, Galapagos NV, Azelis Group NV, Financière de Tubize SA and UCB SA.